MENU
Aim higher

Immune-NOVA

Development of CMTM6 inhibitors: Modulation of PDL1 for cancer treatment

Start date: 
01-03-2019
Project Duration: 
0months
Technological Area: 
Pharmaceutical Products / Drugs
Market Area: 
Monoclonal Antibodies and Hybridomas